As the worldwide industry leader in diagnostics, we are constantly working to improve our products and services. Our expertise in a variety of diagnostic technologies allows us to introduce new and truly innovative products that shape new markets and take diagnostics into new dimensions. This expertise and global presence helps Roche Diagnostics to respond quickly to a variety of global health issues like SARS, and West Nile Virus. In addition, we also have a broad portfolio of diagnostics tools that test for congestive heart failure, HIV, Hepatitis B and C, fertility testing, diabetes, and many other diseases. This wide array of innovative testing products and services is supplied to researchers, physicians, patients, hospitals and laboratories worldwide.
Roche Diagnostics is the global leader in diagnostics and is the
- Global leader in diabetes care
- Global leader in blood screening
- Leader in point-of-care testing
- Leader in virology
- Leader in polymerase chain reaction (PCR) technology
Roche Diagnostics’ Indianapolis campus is home to U.S. research and development, laboratory, manufacturing, distribution, information technology and corporate headquarters operations, in support of five diagnostics business areas: Diabetes Care, Centralized Diagnostics, Applied Science, Molecular Diagnostics and Point-of-Care.
In 2005 sales by the Pharmaceuticals Division totaled 27.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.2 billion Swiss francs. Roche employs roughly 70,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai.
Roche Diagnostics’ North American headquarters is located in Indianapolis, Indiana at (www.roche-diagnostics.us)
For further information about Roche globally, please visit www.roche-diagnostics.com and www.roche.com.
|
